Delivery Order SPE2DB20D1050-SPE2DB25FH87C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,273.92 to AmerisourceBergen Drug Corp for Rifampin 150 mg capsules (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through...
- The Defense Logistics Agency awarded a $2,011.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rifampin 300 mg capsules (quantity 60) on August 13, 2025, with completion targeted for August 14, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The no-set-aside award was competitively awarded and will be...
- The Defense Logistics Agency awarded a delivery order valued at $5,984.18 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (quantity 60) under a firm fixed-price contract valued at $4,135.61, with an ultimate completion date of August 4, 2025. This non-set-aside award was competitively procured and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,816.89 on August 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 14, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. Rifampin is a critical antibiotic used primarily in the treatment of tuberculosis and other mycobacterial infections, making...
- The Defense Logistics Agency awarded a $2,570.68 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Rifampin 300 mg capsules (60 count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Rifampin 300 mg capsules (60-count) with a ceiling value of $3,473.98. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for the supply of Rifampin 300 mg capsules (60-count units) at a ceiling value of $1,720.96. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for ultimate completion by July 29, 2025. The award falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,439.74 on August 14, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 15, 2025, and performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Rifampin 300 mg capsules in unit dose packages of 100 units. This competitively awarded contract, valued at $2,276.64 with firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The order is scheduled for completion by August 18, 2025, with fulfillment performed at the contractor's facility in...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH87CDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,037.35 to AmerisourceBergen Drug Corp for 60 capsules of Rifampin 300 mg, with a completion date of September 2, 2025. The contract employs firm fixed price terms and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order represents a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.9 million through December 2026. This prime vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support global military healthcare programs. Rifampin is an antibiotic commonly used in the treatment of tuberculosis and other mycobacterial infections, reflecting the breadth of pharmaceutical commodities the company delivers to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/29/25 |